In an APP/PS1 transgenic mouse model, NEAT1 is increased and promotes the pathogenesis of AD via upregulating ubiquitination and degradation of PTEN-induced putative kinase 1 (PINK1), which provided a potential therapeutic strategy in AD [145,146]. Here, PSEN1 is linked to Alzheimer disease.